Contract facts
FederalNo full NAICS 325411 intel page yet. Browse NAICS intelligence
4554526190!LEVOFLOXACIN SOLUTION FOR INJ., 750MG/30 is a federal award for Dla Troop Support held by Akorn, Inc. Estimated value $230K ($230K obligated). Current period of performance ends Aug 31, 2021. Place of performance: LAKE FOREST IL.
4554526190!LEVOFLOXACIN SOLUTION FOR INJ., 750MG/30
Recompete timing
PublicCurrent PoP ended Aug 31, 2021 (1816 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SPE2D321F282J?
SPE2D321F282J (4554526190!levofloxacin solution for INJ. 750mg) is a Dla Troop Support award with a potential value of $230K, currently held by Akorn, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded SPE2D321F282J?
Dla Troop Support awarded SPE2D321F282J to Akorn, Inc (potential $230K).
Who is the incumbent on SPE2D321F282J?
Akorn, Inc is the incumbent. The current period of performance ends Aug 31, 2021.
When does Akorn, Inc’s SPE2D321F282J come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.